The AD’OCC agency, the Eurobiomed competitiveness cluster and Inserm, with the support of the Occitanie/Pyrénées-Méditerranée region, are organizing the 2nd edition of:

Biotherapies Days 

November 13 & 14, 2024 

At Montpellier’s Cité de l’Economie et des Métiers de Demain (CEMD) 

Program

Conferences, company pitches, research presentations showcasing the latest scientific discoveries, and updates on regional development projects…

Biotherapies Days is your chance to explore the thriving biotherapies and biomanufacturing ecosystem in Occitanie. The event features the Occitanie Innovation Biotherapy days and the CeBBOc key challenge. It brings together academic, private, and institutional players to foster groundbreaking collaborations.

Join us and meet key industry leaders to discover the upcoming innovations in Occitanie!

Event organization

• November 13, 2024: Occitanie Innovation Biotherapy Day  
• November 13, 2024, from 6pm: Gala evening  
• November 14, 2024: Cell Based Biotherapy Days 

About the Occitanie Innovation Biotherapy sector

As Advanced Therapy Medicinal Products (ATMP) grow and regenerative medicine industrialises more, France’s health industrial sectors shift, intensifying the Occitanie Region’s efforts in launching the Occitanie Innovation Biotherapy Sector.
Occitanie Innovation Biotherapy is a collaborative strategy centred on the biotherapy and bioproduction economic sectors. It unites various regional, academic, and industrial stakeholders across the value chain, with goals to:

• Pool resources in Occitanie for faster biotherapy development and increased economic gains.
• Strengthen regional bioproduction capabilities.
• Unify stakeholders for joint projects, improving project identification and distribution.
• Boost visibility in this growing sector and elevate regional expertise in France and globally.

Occitanie Innovation Biotherapy is overseen by AD’OCC, the Region’s economic development agency, along with Eurobiomed, the competitiveness cluster, and industrial and academic representatives from the sector.

Read more : https://www.agence-adocc.com/biotherapy-innovation-occitanie/

About CeBBOc

Introduced in 2020, the “DEFIS CLES” initiative supports top-quality research on critical issues while aiming to position the Occitanie Region as a frontrunner in future sectors. Additionally, it promotes the development of new skills and future professions. The primary objective is to unite efforts, encourage synergies, and leverage skills, technical expertise, and financial resources to accomplish shared objectives.

In 2022, biotherapy research is among the 11 new “DEFIS CLES” backed by the Occitanie Region, securing a 2-million-euro regional grant for a 4-year action plan implementation.

The “DEFI CLE” CeBBOc (Cell Based Biotherapies Occitanie) aims to invigorate the regional scientific community by concentrating on cell therapies in various forms: native, amplified, modified, within 2D-3D organoid systems, or interacting with biomaterials. It seeks to bolster upstream and translational research, fostering the emergence of new sector technologies. These technologies will play a pivotal role in advancing current objectives across biomedicines, bioproduction, and organoid domains.

Read more : https://www.inserm.fr/delegation/occitanie-pyrenees/

 AD’OCC and sustainable mobility

To limit your ecological footprint, we invite you to opt for carpooling: a simple way of creating links!  

If you’d like to find or offer to carpool, we’ve created a platform just for you: 

An event organized by

Occitanie Innovation Biotherapy contacts : 

Marjorie MONLEAU – Health innovation officer – MONTPELLIER 

Bérénice CHAILLOU – Health innovation officer – TOULOUSE 

CeBBOc contact :  

Camille MALAVAL – Project manager – MONTPELLIER